Evidence map›Paper›PMID 40900469›Full record

ArticleEinstein (Sao Paulo, Brazil)2025

Transrectal prostate biopsy complications: a prospective single center study in a mid-income country.

Allan Jefferson Schollemberg, Flavio Lobo Heldwein, Suelen Dos Santos, Vítor Maurício Merlin Maschietto, Erick Schnorrenberger, Kleber Reinert, Gabriela Garcia Korczaguin, Marcelo Langer Wroclawski

Abstract read
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Allan Jefferson SchollembergHospital Governador Celso Ramos, Florianópolis, SC, Brazil.ORCID http://orcid.org/0009-0008-2757-3374
Flavio Lobo HeldweinDepartment of Urology, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.ORCID http://orcid.org/0000-0003-4321-0078
Suelen Dos SantosDepartment of Urology, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.ORCID http://orcid.org/0000-0001-9977-7941
Vítor Maurício Merlin MaschiettoDepartment of Urology, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.ORCID http://orcid.org/0000-0002-0716-2024
Erick SchnorrenbergerDepartment of Urology, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.ORCID http://orcid.org/0000-0001-7579-2899
Kleber ReinertDepartment of Urology, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.ORCID http://orcid.org/0009-0003-1975-8655
Gabriela Garcia KorczaguinDepartment of Urology, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.ORCID http://orcid.org/0000-0002-1453-7816
Marcelo Langer WroclawskiHospital Israelita Albert Einstein, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0001-6835-9085

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify complications following transrectal posterior biopsies in a public Brazilian reference center, and to identify the risk factors associated with complications.

methodsThis is a prospective cohort study that employed a form designed by the Global Prevalence Infections in Urology study. Data from 1,043 consecutive patients who underwent transrectal prostate biopsy at a single Brazilian center were analyzed, including patient characteristics, procedural characteristics, and self-assessed complications at 28 days. Complications were categorized according to the Clavien-Dindo (CD) classification.

resultsMost bleeding complications were mild (CD Grade 1), although 1.5% reported Grades 2-3. Hypertension, younger age, and anticoagulant use were associated with bleeding (all p<0.001). A total of 4.7% reported infections (CD Grade 2: 0.5%, CD Grade 3: 3.6%, and CD Grade 4 [sepsis]: 0.6%), with risk factors being indwelling catheter use, recent urinary tract infection (p<0.001 for both), and quinolone use (OR= 3.01, 95%CI= 1.15-7.80, p=0.03). Urinary retention was observed in 4.1% (Grade 2), with severe symptoms (p=0.009), prostates >89mL (p=0.001), and prostatic protrusion ≥10mm (p=0.001) being associated with it.

conclusionClinically significant (CD Grades 3-5) adverse effects of transrectal prostate biopsy are rare. Careful pre-procedure evaluation of antimicrobial use, particularly quinolones, along with the assessment of identified risk factors is essential for counseling patients and reducing potential risks.

background■ This prospective cohort study assessed prostate biopsy complications in 1,043 men.

background■ The major outcomes included bleeding (Clavien-Dindo Grades 2-3 = 1.5%), infections (4.7%), and urinary retention (4.1%).

background■ The key risk factors for infection were recent quinolone use, indwelling catheters, and high PSA levels.

background■ Acute urinary retention was linked to untreated lower urinary tract symptoms, prostate volume, intravesical prostatic protrusion, and bladder wall thickness.

backgroundThis prospective study conducted in a mid-income country evaluated the risk factors associated with complications after transrectal prostate biopsy and highlighted significant correlations with hemorrhagic events, infections, and acute urinary retention.

Indexed as

ProstateProstatic NeoplasmsAgedBiopsyBrazilHumansMaleMiddle AgedPostoperative ComplicationsProspective StudiesRectumRisk FactorsUrinary Retention

Identifiers

PMID40900469
PMCPMC12539814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.